ACADIA Pharmaceuticals
ACAD
#3245
Rank
NZ$7.76 B
Marketcap
NZ$45.89
Share price
-0.48%
Change (1 day)
47.55%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): NZ$0.47 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are NZ$1.04 Billion. In 2024 the company made an earning of NZ$0.44 Billion, an increase over its 2023 earnings that were of -NZ$87.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.47 B7.58%
2024 NZ$0.44 B-605.67%
2023 -NZ$87.79 Million-76.09%
2022 -NZ$0.37 Billion27.41%
2021 -NZ$0.29 Billion-40.38%
2020 -NZ$0.49 Billion19.88%
2019 -NZ$0.41 Billion-3.92%
2018 -NZ$0.42 Billion-15.04%
2017 -NZ$0.5 Billion6.33%
2016 -NZ$0.47 Billion64.55%
2015 -NZ$0.29 Billion77.47%
2014 -NZ$0.16 Billion143.69%
2013 -NZ$65.28 Million81.93%
2012 -NZ$35.88 Million-8.73%
2011 -NZ$39.31 Million-251.39%
2010 NZ$25.96 M-133.2%
2009 -NZ$78.21 Million-30.82%
2008 -NZ$0.12 Billion6.43%
2007 -NZ$0.11 Billion25.89%
2006 -NZ$84.38 Million36.99%
2005 -NZ$61.59 Million37.22%
2004 -NZ$44.89 Million19.96%
2003 -NZ$37.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Vanda Pharmaceuticals
VNDA
-NZ$0.21 Billion-144.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.38 B 4,230.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.70 B 8,122.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.72 B 11,737.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.81 B 2,835.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-NZ$66.45 Million-114.12%๐Ÿ‡บ๐Ÿ‡ธ USA